Institute Of Hematology & Blood Diseases Hospital, China

This study is testing a targeted drug called inotuzumab ozogamicin for adults with a type of acute lymphoblastic leukemia (ALL). It is for patients who have responded to initial chemotherapy but still have very low levels of detectable cancer cells, known as minimal residual dise…

This study is testing a combination of two advanced immunotherapies for people with B-cell Non-Hodgkin lymphoma that has come back or not responded to standard treatments. The goal is to see if using a bispecific antibody drug together with engineered immune cells (CAR-T cells) i…

This study aims to understand the real-world costs, treatment patterns, and patient experiences of living with severe hemophilia in China. It will enroll 500 male patients aged 12 and older to collect data on their care, expenses, and quality of life. The goal is to identify gaps…

This study follows 2000 people who stored umbilical cord blood in Tianjin, China, to understand how their health develops over time. Researchers will track what diseases occur and explore how genetics, environment, and lifestyle choices affect health outcomes. This is an observat…